REGN5381 in Heart Failure Adult Participants With Elevated Pulmonary Capillary Wedge Pressure

NCT05353166 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: REGN5381
DRUG: Matching Placebo

Sponsor

Regeneron Pharmaceuticals